Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meditoxin for cervical dystonia in adults with cerebral palsy
NCT01860196Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2013
- Primary completion
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, double-blind trial of Meditoxin in cervical dystonia (CD), sponsored by Seoul National University Hospital. Primary endpoint: Toronto Western Spasmodic Torticollis Rating Scale at 32 weeks. Started Jun 2013; status: completed.
02
Drugs
Meditoxin
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT01860196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860196.